← Back to Search

Shared Decision-Making Strategy for Lung Cancer Screening

N/A

Waitlist Available

Led By Ronald Myers

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the date of randomization to the date of screening (for those screened) or to the date of the review (for those not screened, "censored", assessed at 3 months

Awards & highlights

Study Summary

This trial is studying how well a proactive outreach and shared decision making strategy works in improving lung cancer screening rates in primary care patients.

Who is the study for?

This trial is for primary care patients who have a history of smoking, as noted in their electronic health records. They must have seen their primary care physician recently at one of the study practices. People cannot join if they've had a lung cancer screening test called LDCT in the past year or if they already have a lung cancer diagnosis on record.Check my eligibility

What is being tested?

The trial is testing whether proactive outreach and shared decision-making can help improve lung cancer screening rates among patients. It aims to see if these strategies lead to earlier detection of lung cancer by encouraging more people to get screened.See study design

What are the potential side effects?

Since this trial involves behavioral, psychological or informational interventions rather than medications, traditional side effects are not expected. However, participants may experience increased anxiety or stress related to discussions about lung cancer risk and screening.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from the date of randomization to the date of screening (for those screened) or to the date of the review (for those not screened, "censored", assessed at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from the date of randomization to the date of screening (for those screened) or to the date of the review (for those not screened, "censored", assessed at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from the date of randomization to the date of screening (for those screened) or to the date of the review (for those not screened, "censored", assessed at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

X-Ray Computed Tomography

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Group III (outreach + Decision Counseling Program)Experimental Treatment3 Interventions

Patients receive educational materials in the mail about lung cancer screening with a cover letter from their physician. A week later, they receive a phone call from the study staff to assess their eligibility. Patients then undergo a decision counseling session through a semi-structured Decision Counseling Program that includes a review of the mailed educational materials and completion of an interactive exercise intended to clarify personal preference related to screening options (to have LDCT or not to have LDCT). Patients interested in screening schedule an office visit at JLCSP for possible screening or are referred to their primary care physician for consultation.

Group II: Group II (outreach contact)Experimental Treatment2 Interventions

Patients receive educational materials in the mail about lung cancer screening with a cover letter from their physician. A week later, they receive a phone call from the study staff to assess their eligibility. Eligible and interested patients receive an office visit at the JLCSP for shared decision-making and possible lung cancer screening.

Group III: Group 1 (usual care)Active Control1 Intervention

receive usual care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

444 Previous Clinical Trials

143,269 Total Patients Enrolled

Ronald MyersPrincipal InvestigatorSidney Kimmel Cancer Center at Thomas Jefferson University

Media Library

Cancer Educational Materials Clinical Trial Eligibility Overview. Trial Name: NCT03929926 — N/A

Lung Cancer Research Study Groups: Group II (outreach contact), Group 1 (usual care), Group III (outreach + Decision Counseling Program)

Lung Cancer Clinical Trial 2023: Cancer Educational Materials Highlights & Side Effects. Trial Name: NCT03929926 — N/A

Cancer Educational Materials 2023 Treatment Timeline for Medical Study. Trial Name: NCT03929926 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must a person satisfy in order to become part of this clinical trial?

"To be eligible for this study, lung cancer patients must fit between the ages of 55 and 80 years old. The trial is looking to recruit up to 2,355 participants total."

Answered by AI

Does the stipulation for eligibility in this trial encompass individuals beneath 25 years of age?

"All potential participants in this trial must be of ager greater than 55 years and not exceed the age of 80."

Answered by AI

Are there any openings still available to participate in this experiment?

"Data hosted on clinicaltrials.gov reveals that this medical research is no longer recruiting subjects. The trial was first announced in June of 2019, and last updated in September 2021. Despite the cessation of enrollment for this particular study, 1631 other trials are still seeking participants at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients

2019. "Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03929926.